17/07/2025
Helping patients live not just longer, but better! 💪🏻💪🏻
Peripheral numbness of the hands and feet is a common side of chemotherapy, occurring in up to 60% of patients who receive treatment for their cancers. While many other side effects of chemotherapy resolve after completion of treatment, peripheral numbness can persist in some patients, affecting patient’s long-term quality of life 🧠🖐🦶.
Curie Oncology has partnered the National University Cancer Institute, Singapore, National University Singapore, and Paxman Systems to run a clinical trial investigating the use of limb cooling❄️to decrease the risk of developing chemotherapy-induced peripheral numbness.
At the Multinational Association of Supportive Care in Cancer Annual Meeting 2025 held in Seattle, Dr Joline Lim shared the interim results of this trial, that showed that patients who underwent limb cooling concurrently while undergoing chemotherapy had lower rates of developing peripheral numbness compared to previous studies, both from physician assessment and patient reported outcomes. This technology is currently being investigated in a large randomized study in the United States, and may potentially provide a new solution for patients to prevent onset of chemotherapy-induced peripheral numbness.
We are pleased to partner and .nuhs to be part of this novel innovation, and have the opportunity to offer both scalp and limb cooling to decrease chemotherapy induced hair loss💇and peripheral numbness, taking steps to allow our patients to live better during their cancer journey💪💖!
